Proteomic Response of Oral and Intestinal Epithelial Cells to HIV

口腔和肠道上皮细胞对 HIV 的蛋白质组反应

基本信息

项目摘要

Recent work has suggested that disruption of the intestinal epithelium in the acute phase of HIV infection is associated with systemic immune activation and loss of intestinal followed by systemic CD4+ T cells. The mechanism by which HIV disrupts intestinal epithelial cells (lECs) has not been determined, nor is it known if effects of HIV on the intestinal epithelium are indirect, direct, or both. Epithelial HIV penetration has been reported for human oral epithelial cells (HOECs) using in vitro studies to demonstrate that oral epithelial cells are susceptible to cell free and cell-associated HIV challenge. In contrast, epidemiological evidence indicates that exogenous infection with HIV-1 through oral tissue epithelium is an uncommon event; certainly when compared to the risks for infection through either the genital or rectal mucosa. Given the differential susceptibilities of various tissue mucosa to HIV infection, understanding the role the epithelium plays in protection against HIV infection is important. We hypothesize that oral mucosal epithelium compared to intestinal epithelium has inherent properties that contribute to its resistance to HIV-1 transcytosis and subsequent infection. The proteome of oral and intestinal epithelial cells in HIV-seropositive subjects compared to uninfected subjects has not been defined. In addition to potential epithelial innate response elements that could elicit protection against HIV-1, we must also consider impaired cellular responses in HIV+ subjects that can be confounded by co-infections such as hepatitis C virus (HCV), commonly found in drug abusive HIV4" individuals. Using 2D-DIGE assessment of HOECs from HIV+ and HIV individuals, we identified differential protein expression profiles between HIV-infected and non-infected individuals. Understanding the role that the epithelium plays in HIV infection and inherent differential susceptibility properties of epithelial tissues derived from various anatomic locations is therefore of interest. The specific aims of this pilot and feasibility study are to: 1.)Compare proteomic profiles of human oral epithelial cells (HOECs) and intestinal epithelial cells (lECs) from HIV, HIV+(on HAART), HIV*/HCV+(on HAART) and HCV* subjects, and 2.) Compare proteomic profiles of (HIV) HOECs and lECs challenged in vitro with HIV, and opioids.
最近的研究表明,在HIV感染的急性期,肠上皮的破坏是HIV感染的主要原因

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS S MCCORMICK其他文献

THOMAS S MCCORMICK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS S MCCORMICK', 18)}}的其他基金

Differential Diagnosis of recurrent GBM versus Radiation Necrosis using MDSCbiomarkers
使用 MDSC 生物标志物鉴别诊断复发性 GBM 与放射性坏死
  • 批准号:
    10330027
  • 财政年份:
    2021
  • 资助金额:
    $ 13.92万
  • 项目类别:
Animal Experimentation Core
动物实验核心
  • 批准号:
    7665015
  • 财政年份:
    2008
  • 资助金额:
    $ 13.92万
  • 项目类别:
Animal Experimentation Core
动物实验核心
  • 批准号:
    7502321
  • 财政年份:
    2007
  • 资助金额:
    $ 13.92万
  • 项目类别:
CORE--ANIMAL EXPERIMENTATION
核心——动物实验
  • 批准号:
    6588775
  • 财政年份:
    2002
  • 资助金额:
    $ 13.92万
  • 项目类别:
Proj. 3 - Proteomic Response of Epithelial Cell Interactions with HIV
项目。
  • 批准号:
    8462470
  • 财政年份:
  • 资助金额:
    $ 13.92万
  • 项目类别:
Core D: Animal Experimentation & Wound Healing
核心 D:动物实验
  • 批准号:
    8203935
  • 财政年份:
  • 资助金额:
    $ 13.92万
  • 项目类别:
Proteomic Response of Oral and Intestinal Epithelial Cells to HIV
口腔和肠道上皮细胞对 HIV 的蛋白质组反应
  • 批准号:
    7617381
  • 财政年份:
  • 资助金额:
    $ 13.92万
  • 项目类别:
Proj. 3 - Proteomic Response of Epithelial Cell Interactions with HIV
项目。
  • 批准号:
    7685067
  • 财政年份:
  • 资助金额:
    $ 13.92万
  • 项目类别:
Proteomic Response of Oral and Intestinal Epithelial Cells to HIV
口腔和肠道上皮细胞对 HIV 的蛋白质组反应
  • 批准号:
    8248801
  • 财政年份:
  • 资助金额:
    $ 13.92万
  • 项目类别:
Proj. 3 - Proteomic Response of Epithelial Cell Interactions with HIV
项目。
  • 批准号:
    8254424
  • 财政年份:
  • 资助金额:
    $ 13.92万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 13.92万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了